Versuchen GOLD - Frei

Great ideas and innovation always come from startups

Express Pharma

|

December 2025

Sattvam Life Science is a company pioneering advancements in green chemistry, biomanufacturing and Al-driven process development. Dr Pundalik Pednekar, Founder and MD, Sattvam Life Science shares his insights on the company's journey, its innovation-led growth, and its mission to make Indian science a global benchmark for quality and responsibility, in conversation with Swati Rana

Great ideas and innovation always come from startups

Can you share the thought behind the establishment of Sattvam Life Science and what inspired its foundation?

Sattvam Life Science was founded with a vision to build a science-driven, innovation-led pharma company rooted in integrity, quality, and sustainability – offering end-to-end solutions from drug substance to drug products. Our expertise spans advanced chemistry disciplines, including synthetic chemistry, biopharmaceuticals, nutraceuticals, and bioenzymatic catalyst-based chemistry. We also focus on developing continuous processes, such as flow chemistry, to reduce waste and carbon footprint.

After years of experience in the life sciences and specialty chemicals sector, I recognised a clear gap – the need for an agile Indian company focused on value creation through advanced chemistry and responsible manufacturing.

The idea behind Sattvam was not merely to produce pharmaceuticals, but to redefine how science can serve humanity – by integrating green chemistry, digital technology, and scalable innovation. “Sattvam,” derived from Sanskrit, symbolises purity, balance, and knowledge – the very principles that guide our organisation.

Great ideas and innovations often originate from startups, and Sattvam embodies that spirit.

What are the key growth drivers for the company since its inception?

Our growth has been driven by three major pillars:

● Innovation at the core – focusing on process development, biotransformation, and technology-enabled manufacturing.

● Commitment to quality – aligning systems with global standards such as WHO, USFDA, and EU-GMP.

● Customer-centric approach – building long-term partnerships and customized solutions rather than transactional engagements.

Additionally, our emphasis on cost-effective and sustainable manufacturing has made us competitive both in India and globally.

WEITERE GESCHICHTEN VON Express Pharma

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Listen

Translate

Share

-
+

Change font size